Moderna (MRNA) PT Raised to $115 at BofA Securities
Tweet
Share
E-mail
Get Alerts MRNA Hot Sheet
Price: $150.81 -2.24%
Rating Summary:
7 Buy, 21 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 11 | New: 32
Rating Summary:
7 Buy, 21 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 11 | New: 32
Join SI Premium – FREE
BofA Securities analyst Geoff Meacham raised the price target on Moderna (NASDAQ: MRNA) to $115.00 (from $110.00) while maintaining a Underperform rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Argus Upgrades Moderna (MRNA) to Buy
- MiniMed Group (MMED) PT Raised to $27 at StoneX on Conservative Revenue Guide
- Wedbush Downgrades Tscan Therapeutics Inc (TCRX) to Neutral
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
